肝包虫病的治疗现状及进展  

The Status and Progress in the Treatment of Hepatic Echinococcosis

作　　者：米园园[1] 樊静[1] 马淑杰[1] 张铁民[1] 

机构地区：[1]哈尔滨医科大学附属第一医院结肠直肠外科,哈尔滨150001

出　　处：《医学综述》2015年第18期3328-3330,共3页Medical Recapitulate

基　　金：黑龙江省教育厅科学技术研究项目(11531173)

摘　　要：包虫病是由棘球蚴寄生于人体而引起的慢性、可危及人性命的人兽共患病,是一个世界范围内的重要公共卫生问题,影响着许多地区的经济发展。棘球蚴感染后以其囊肿寄生于人体,肝和肺的寄生最常见,约占70%和20%,其余10%分布于各组织器官。目前肝包虫病的治疗主要以手术治疗为主,微创、药物治疗以及免疫预防为辅。肝包虫病的治疗方法纷繁复杂、各有利弊。分析各种治疗方法的优缺点有利于进一步深入而全面地认识肝包虫病的治疗。Hydatid disease,an ancient,chronic,life-threatening disease caused by infection with larval stage of the tapeworm Echinococcus granulosus,represents a significant worldwide public health problem and a socioeconomic concern in many areas of the world. Larval cysts as unilocular fluid-filled bladders develop in the visceral tissue,mainly in the liver（ 70%）,but also lungs（ 20%） and 10% of cysts can be found in other organs. At present,the treatment of hepatic echinococcosis still mainly relies on surgery,assisted with minimally invasive treatment,drug therapy and immune prevention. There are a lot of methods to treat hepatic echinococcosis,each with own advantages and disadvantages. Analysis of the advantages and disadvantages of various methods conhelp to further and comprehensively understand the treatment of hepatic echinococcosis.

关 键 词：包虫病 手术治疗 微创治疗 药物治疗 免疫预防 

分 类 号：R532.32[医药卫生—内科学]